MarginsXMarginsX
Home › Markets › Health Care › ITOC

iTonic Holdings Ltd (ITOC)

ITOC trades on Nasdaq in Health Care, Biotechnology: Electromedical & Electrotherapeutic Apparatus. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$1.88
-5.05% on the day
Market cap
$13.8M
Nano cap
Revenue · 2025
$523K
+16.7% on 2024
Net income · 2025
-$5.1M
-974.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F/A (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1970544/000121390026039356/0001213900-26-039356-index.htm. Net income: SEC 20-F/A (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerITOC on Nasdaq
SectorHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic Apparatus
CountryChina
IPO year2024
SEC CIK0001970544
SEC industry codeElectromedical & Electrotherapeutic Apparatus

Financials · 2025

LineValue
Revenue$523K
Net income-$5.1M
Operating income-$5.2M
Net margin-974.7%
Operating margin-991.7%
Revenue growth+16.7%
Cash$1.5M
Total assets$9.1M
P/E (computed)Net income was not positive
P/S (computed)26.3×

Warning signs

Cash runway
5.5 months
$1.5M cash at December 31, 2025
Share count, 1 year
See the dilution note
Going-concern doubt
Yes
20-F filed March 30, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"These factors raise substantial doubt regarding the Company's ability to continue as a going concern."
20-F 2026-03-30
Cash and burn$1.5M cash; operating cash flow -$808K a quarter.Report 2025-12-31
Shares outstandingNo cover-page share count in XBRLCover page 2025-12-31
Reverse splits, 3 years1; latest 1-for-16 on 2026-10-06Source 2026-10-06
Shelf and offerings, 12 months1 S-3/F-3 shelf filings; 0 424B5 takedownsLatest 2026-02-06
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorFORTUNE CPA, INC, Garden Grove, California, United StatesPCAOB Form AP 2026-04-21
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Annual results

Fiscal yearRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
FY 2025
2025-12-31
$523K-$5.1M-$3.2M$1.5MNo debt tags$523K20-F/A 2026-04-02
FY 2024
2024-12-31
$448K-$661K-$775K$6.2MNo debt tags$448K20-F/A 2026-04-02
FY 2023
2023-12-31
$629K-$241K-$64K$218KNo debt tags$629K20-F/A 2026-04-02
FY 2022
2022-12-31
$680K$84K-$116K$72KNo debt tags$680K20-F 2025-03-20

From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
F-32026-02-06
Latest annual report
ANNUAL REPORT
20-F2026-03-30
Latest quarterly / interim
REPORT OF FOREIGN PRIVATE ISSUER
6-K2026-10-02

Source: SEC EDGAR submissions feed, 84 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+15.1%
1 month-49.7%
3 months-57.5%
Year to date-70.6%
1 year-79.8%
From 52-week high-86.3%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Electromedical & Electrotherapeutic Apparatus

TickerCompanyPriceDayMarket cap
IRIXIRIDEX Corporation$0.6878-0.32%$12.1M
QTIQT Imaging Holdings Inc.$1.80-4.26%$26.4M
NDRAENDRA Life Sciences Inc.$4.42-1.78%$6.6M
ECORelectroCore Inc.$4.84-7.81%$44.7M
POCIPrecision Optics Corporation Inc.$4.97-4.97%$54.6M
OMOutset Medical Inc.$3.39-9.12%$64.0M
HYPRHyperfine Inc.$0.6101-3.05%$64.8M
NRXSNeuraxis Inc.$4.80-11.44%$68.1M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier